Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals
- Author
- FOSBØL, Emil Loldrup1 ; FOLKE, Fredrik1 ; TORP-PEDERSEN, Christian1 ; GISLASON, Gunnar H1 ; JACOBSEN, Søren2 ; RASMUSSEN, Jeppe N3 ; SØRENSEN, Rikke1 ; SCHRAMM, Tina Ken1 ; ANDERSEN, Søren S1 ; RASMUSSEN, Søren3 ; POULSEN, Henrik Enghusen4 ; KØBER, Lars5
[1] Department of Cardiology, Gentofte University Hospital, Hellerup, Denmark
[2] Department of Rheumatology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
[3] National Institute of Public Health, Copenhagen, Denmark
[4] Department of Clinical Pharmacology, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark
[5] Heart Centre, Copenhagen University Hospital Rigshospitalet, Copenhagen, Denmark - Source
Circulation. Cardiovascular quality and outcomes (Print). 2010, Vol 3, Num 4, pp 395-405, 11 p ; ref : 38 ref
- ISSN
- 1941-7713
- Scientific domain
- Cardiology, blood circulation, phlebology
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Author keyword
- bleeding complications cardiovascular death cause-specific mortality myocardial infarction nonsteroidal antiinflammatory drugs selective cyclooxygenase-2 inhibitors stroke
- Keyword (fr)
- Accident cérébrovasculaire Athérosclérose Complication Facteur risque Homme Hémorragie Individu sain Infarctus du myocarde Inhibiteur cyclooxygenase 2 Mort Mortalité Médicament Pathologie de l'appareil circulatoire Pronostic Antiinflammatoire non stéroïde Cardiopathie coronaire Pathologie cérébrovasculaire Pathologie de l'encéphale Pathologie des vaisseaux sanguins Pathologie du myocarde Pathologie du système nerveux central Pathologie du système nerveux
- Keyword (en)
- Stroke Atherosclerosis Complication Risk factor Human Hemorrhage Healthy subject Myocardial infarction Cyclooxygenase 2 inhibitor Death Mortality Drug Cardiovascular disease Prognosis Non steroidal antiinflammatory agent Coronary heart disease Cerebrovascular disease Cerebral disorder Vascular disease Myocardial disease Central nervous system disease Nervous system diseases
- Keyword (es)
- Accidente cerebrovascular Ateroesclerosis Complicación Factor riesgo Hombre Hemorragia Individuo sano Infarto miocardio Inhibidor cyclooxygenase 2 Muerte Mortalidad Medicamento Aparato circulatorio patología Pronóstico Antiinflamatorio no esteroide Cardiopatía coronaria Vaso sanguíneo encéfalo patología Encéfalo patología Vaso sanguíneo patología Miocardio patología Sistema nervosio central patología Sistema nervioso patología
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02L Bones, joints and connective tissue. Antiinflammatory agents
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12A Heart / 002B12A03 Coronary heart disease
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B12 Cardiology. Vascular system / 002B12B Blood and lymphatic vessels / 002B12B01 Atherosclerosis (general aspects, experimental research)
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B17 Neurology / 002B17C Vascular diseases and vascular malformations of the nervous system
- Discipline
- Cardiology. Circulatory system Neurology Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 23112495
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1161/CIRCOUTCOMES.109.861104 
https://dx.doi.org/10.1161/CIRCOUTCOMES.109.861104
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1161\/CIRCOUTCOMES.109.861104\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals\";s:9:\"\u0000*\u0000jtitle\";s:56:\"Circulation. Cardiovascular quality and outcomes (Print)\";s:9:\"\u0000*\u0000stitle\";s:41:\"Circ., Cardiovasc. qual. outcomes (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:1:\"3\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"395\";s:8:\"\u0000*\u0000epage\";s:3:\"405\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1941-7713\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FOSB\u00d8L\";s:10:\"\u0000*\u0000aufirst\";s:12:\"Emil Loldrup\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:14:\"FOLKE, Fredrik\";i:1;s:24:\"TORP-PEDERSEN, Christian\";i:2;s:18:\"GISLASON, Gunnar H\";i:3;s:16:\"JACOBSEN, S\u00f8ren\";i:4;s:18:\"RASMUSSEN, Jeppe N\";i:5;s:16:\"S\u00d8RENSEN, Rikke\";i:6;s:17:\"SCHRAMM, Tina Ken\";i:7;s:18:\"ANDERSEN, S\u00f8ren S\";i:8;s:17:\"RASMUSSEN, S\u00f8ren\";i:9;s:24:\"POULSEN, Henrik Enghusen\";i:10;s:12:\"K\u00d8BER, Lars\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1161\/CIRCOUTCOMES.109.861104\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals\";s:9:\"\u0000*\u0000jtitle\";s:56:\"Circulation. Cardiovascular quality and outcomes (Print)\";s:9:\"\u0000*\u0000stitle\";s:41:\"Circ., Cardiovasc. qual. outcomes (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:1:\"3\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"395\";s:8:\"\u0000*\u0000epage\";s:3:\"405\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1941-7713\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FOSB\u00d8L\";s:10:\"\u0000*\u0000aufirst\";s:12:\"Emil Loldrup\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:14:\"FOLKE, Fredrik\";i:1;s:24:\"TORP-PEDERSEN, Christian\";i:2;s:18:\"GISLASON, Gunnar H\";i:3;s:16:\"JACOBSEN, S\u00f8ren\";i:4;s:18:\"RASMUSSEN, Jeppe N\";i:5;s:16:\"S\u00d8RENSEN, Rikke\";i:6;s:17:\"SCHRAMM, Tina Ken\";i:7;s:18:\"ANDERSEN, S\u00f8ren S\";i:8;s:17:\"RASMUSSEN, S\u00f8ren\";i:9;s:24:\"POULSEN, Henrik Enghusen\";i:10;s:12:\"K\u00d8BER, Lars\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:31:\"10.1161\/CIRCOUTCOMES.109.861104\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1161\/CIRCOUTCOMES.109.861104\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals\";s:9:\"\u0000*\u0000jtitle\";s:56:\"Circulation. Cardiovascular quality and outcomes (Print)\";s:9:\"\u0000*\u0000stitle\";s:41:\"Circ., Cardiovasc. qual. outcomes (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:1:\"3\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"395\";s:8:\"\u0000*\u0000epage\";s:3:\"405\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1941-7713\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FOSB\u00d8L\";s:10:\"\u0000*\u0000aufirst\";s:12:\"Emil Loldrup\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:14:\"FOLKE, Fredrik\";i:1;s:24:\"TORP-PEDERSEN, Christian\";i:2;s:18:\"GISLASON, Gunnar H\";i:3;s:16:\"JACOBSEN, S\u00f8ren\";i:4;s:18:\"RASMUSSEN, Jeppe N\";i:5;s:16:\"S\u00d8RENSEN, Rikke\";i:6;s:17:\"SCHRAMM, Tina Ken\";i:7;s:18:\"ANDERSEN, S\u00f8ren S\";i:8;s:17:\"RASMUSSEN, S\u00f8ren\";i:9;s:24:\"POULSEN, Henrik Enghusen\";i:10;s:12:\"K\u00d8BER, Lars\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1161\/CIRCOUTCOMES.109.861104\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals\";s:9:\"\u0000*\u0000jtitle\";s:56:\"Circulation. Cardiovascular quality and outcomes (Print)\";s:9:\"\u0000*\u0000stitle\";s:41:\"Circ., Cardiovasc. qual. outcomes (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:1:\"3\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"395\";s:8:\"\u0000*\u0000epage\";s:3:\"405\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1941-7713\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FOSB\u00d8L\";s:10:\"\u0000*\u0000aufirst\";s:12:\"Emil Loldrup\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:14:\"FOLKE, Fredrik\";i:1;s:24:\"TORP-PEDERSEN, Christian\";i:2;s:18:\"GISLASON, Gunnar H\";i:3;s:16:\"JACOBSEN, S\u00f8ren\";i:4;s:18:\"RASMUSSEN, Jeppe N\";i:5;s:16:\"S\u00d8RENSEN, Rikke\";i:6;s:17:\"SCHRAMM, Tina Ken\";i:7;s:18:\"ANDERSEN, S\u00f8ren S\";i:8;s:17:\"RASMUSSEN, S\u00f8ren\";i:9;s:24:\"POULSEN, Henrik Enghusen\";i:10;s:12:\"K\u00d8BER, Lars\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:31:\"10.1161\/CIRCOUTCOMES.109.861104\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:112:\"Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals\";s:9:\"\u0000*\u0000jtitle\";s:56:\"Circulation. Cardiovascular quality and outcomes (Print)\";s:9:\"\u0000*\u0000stitle\";s:41:\"Circ., Cardiovasc. qual. outcomes (Print)\";s:7:\"\u0000*\u0000date\";s:4:\"2010\";s:9:\"\u0000*\u0000volume\";s:1:\"3\";s:8:\"\u0000*\u0000issue\";s:1:\"4\";s:8:\"\u0000*\u0000spage\";s:3:\"395\";s:8:\"\u0000*\u0000epage\";s:3:\"405\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"1941-7713\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"FOSB\u00d8L\";s:10:\"\u0000*\u0000aufirst\";s:12:\"Emil Loldrup\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:11:{i:0;s:14:\"FOLKE, Fredrik\";i:1;s:24:\"TORP-PEDERSEN, Christian\";i:2;s:18:\"GISLASON, Gunnar H\";i:3;s:16:\"JACOBSEN, S\u00f8ren\";i:4;s:18:\"RASMUSSEN, Jeppe N\";i:5;s:16:\"S\u00d8RENSEN, Rikke\";i:6;s:17:\"SCHRAMM, Tina Ken\";i:7;s:18:\"ANDERSEN, S\u00f8ren S\";i:8;s:17:\"RASMUSSEN, S\u00f8ren\";i:9;s:24:\"POULSEN, Henrik Enghusen\";i:10;s:12:\"K\u00d8BER, Lars\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:0:\"\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:112:\"Cause-Specific Cardiovascular Risk Associated With Nonsteroidal Antiinflammatory Drugs Among Healthy Individuals\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:2:\"11\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
